| Date | Title | Description | |
|---|---|---|---|
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
| 21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
| 21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
| 21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download |
| 21 Feb 2023 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 24 Feb 2021 | Annual Corporate Governance Report | ROVI releases the 2020 Annual Corporate Governance Report | Download |
| 24 Feb 2021 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors | Download |
| 11 Jan 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2020 | Download |
| 24 Nov 2020 | On business and financial situation | The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day. | Download |
| 13 Nov 2020 | Other relevant information | The Company informs about the dividends payment | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 21 Feb 2013 | Información sobre resultados (2) | Download | |
| 21 Feb 2013 | Información sobre resultados | Download | |
| 21 Feb 2013 | Informe Anual de Gobierno Corporativo 2012 | Download | |
| 08 Nov 2012 | Información financiera intermedia | Download | |
| 08 Nov 2012 | Información sobre resultados | Download |